Northern Trust’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-41,285
Closed -$5.37K 4662
2023
Q1
$5.37K Hold
41,285
﹤0.01% 4562
2022
Q4
$6.78K Hold
41,285
﹤0.01% 4608
2022
Q3
$27K Hold
41,285
﹤0.01% 4493
2022
Q2
$100K Sell
41,285
-5,640
-12% -$15.7K ﹤0.01% 4170
2022
Q1
$190K Sell
46,925
-1,537
-3% -$8.43K ﹤0.01% 4151
2021
Q4
$388K Buy
48,462
+5,593
+13% +$65.6K ﹤0.01% 3902
2021
Q3
$827K Sell
42,869
-1,644
-4% -$28.7K ﹤0.01% 3610
2021
Q2
$614K Buy
44,513
+8,581
+24% +$102K ﹤0.01% 3646
2021
Q1
$324K Buy
35,932
+25,889
+258% +$189K ﹤0.01% 3955
2020
Q4
$55K Buy
+10,043
New +$44.4K ﹤0.01% 4224
2020
Q2
Sell
-10,980
Closed -$25K 4321
2020
Q1
$25K Hold
10,980
﹤0.01% 4062
2019
Q4
$48K Sell
10,980
-23
-0.2% -$108 ﹤0.01% 4065
2019
Q3
$57K Sell
11,003
-100
-0.9% -$582 ﹤0.01% 4037
2019
Q2
$80K Hold
11,103
﹤0.01% 4007
2019
Q1
$59K Buy
+11,103
New +$54.3K ﹤0.01% 4021
2017
Q2
Sell
-1,600
Closed -$17K 4311
2017
Q1
$17K Sell
1,600
-3,138
-66% -$34.1K ﹤0.01% 4169
2016
Q4
$60K Buy
4,738
+65
+1% +$2.39K ﹤0.01% 3986
2016
Q3
$542K Buy
4,673
+468
+11% +$45.6K ﹤0.01% 3494
2016
Q2
$333K Buy
4,205
+230
+6% +$19.9K ﹤0.01% 3599
2016
Q1
$303K Hold
3,975
﹤0.01% 3600
2015
Q4
$356K Buy
3,975
+238
+6% +$22.8K ﹤0.01% 3586
2015
Q3
$419K Buy
3,737
+2,317
+163% +$267K ﹤0.01% 3537
2015
Q2
$144K Buy
+1,420
New +$147K ﹤0.01% 3863

Other funds holding PLXP

Northern Trust's PLXP Position: Q2 2023 in Review

Northern Trust sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 41,285 shares — an estimated $5.37K sold.

Northern Trust first reported a position in PLXP in Q2 2015 and held it in 23 quarters. The position peaked at $827K in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Northern Trust reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Northern Trust sold 41,285 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $5.37K.
  • Northern Trust first reported a position in PLx Pharma Inc. Common Stock in Q2 2015 and held it in 23 quarters.
  • Northern Trust's PLx Pharma Inc. Common Stock position peaked at $827K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.